The "GLI2 Gene Holoprosencephaly-Type 9 Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at detecting mutations in the GLI2 gene, which are associated with Holoprosencephaly-Type 9 (HPE9). Holoprosencephaly is a complex brain malformation disorder characterized by the failure of the forebrain to develop into two distinct hemispheres, leading to various neurological and physical abnormalities. The GLI2 gene plays a crucial role in early brain development, and mutations in this gene can lead to HPE9, making this test essential for early diagnosis and management of the condition.
Priced at 4400 AED, the test involves analyzing the patient's DNA to identify any genetic alterations in the GLI2 gene that might predispose them to this form of holoprosencephaly. Early detection through this genetic test can be pivotal in managing the condition, allowing healthcare providers to offer tailored treatments and interventions that can significantly improve the quality of life for affected individuals. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a critical tool in the genetic diagnosis and understanding of Holoprosencephaly-Type 9.
The TBX5 Gene Holt-Oram Syndrome Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to detect mutations in the TBX5 gene, which are responsible for Holt-Oram syndrome. Holt-Oram syndrome is a genetic disorder characterized by skeletal abnormalities of the hands and arms (upper limbs) and heart defects. This condition follows an autosomal dominant pattern of inheritance, meaning a mutation in just one of the two copies of the gene is sufficient to cause the disorder.
The test, priced at 4400 AED, involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any genetic alterations in the TBX5 gene. Early detection through this genetic test is crucial as it allows for timely management and treatment of the syndrome's manifestations, particularly the cardiac issues that can be life-threatening if not addressed promptly.
DNA Labs UAE, by offering this test, provides a critical resource for families with a history of Holt-Oram syndrome or for individuals presenting symptoms related to the disorder, enabling them to make informed decisions about their health and future.
The LMNA Gene Hutchinson-Gilford Progeria Genetic Test is a specialized diagnostic assessment performed to detect mutations in the LMNA gene, which are responsible for Hutchinson-Gilford Progeria Syndrome (HGPS). This rare genetic disorder is characterized by accelerated aging in children, leading to premature death usually due to heart disease. The test involves analyzing the patient's DNA to identify specific mutations in the LMNA gene that cause the production of an abnormal protein known as progerin. This protein is the key factor behind the rapid aging process associated with the syndrome.
Conducted at DNA Labs UAE, this test is crucial for the early detection and management of Hutchinson-Gilford Progeria Syndrome. Early diagnosis can help in the management of symptoms and in some cases, may prolong the life expectancy of the affected individual. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to accurately interpret the results. By identifying the presence of the LMNA gene mutation, this test provides essential information for families and healthcare providers, paving the way for potential treatment options and supportive care measures tailored to the unique needs of the patient.
The FLVCR2 Gene Hydranencephaly Fowler Type Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the FLVCR2 gene, which are associated with Fowler syndrome. Fowler syndrome is a rare genetic condition characterized by hydranencephaly, where the brain's cerebral hemispheres are largely absent and replaced with sacs filled with cerebrospinal fluid. This condition is typically fatal, and affected infants often have a poor prognosis.
The test is crucial for early detection and understanding of the genetic underpinnings of this condition, enabling healthcare providers to offer accurate genetic counseling to affected families. By examining the FLVCR2 gene, this test can confirm a diagnosis of Fowler syndrome, helping in the management and planning for the care of affected individuals.
The cost of the FLVCR2 Gene Hydranencephaly Fowler Type Genetic Test at DNA Labs UAE is set at 4400 AED. This investment includes the comprehensive analysis necessary to identify the specific mutations within the FLVCR2 gene that are indicative of Fowler syndrome. DNA Labs UAE is equipped with state-of-the-art genetic testing technology and staffed by professionals skilled in the interpretation of genetic data, ensuring that patients and their families receive accurate and meaningful results.
The HYLS1 gene plays a critical role in human development, and mutations in this gene are associated with Hydrolethalus Syndrome (HLS), a rare genetic disorder characterized by severe malformations in the fetus, leading to prenatal or early postnatal death. Given the critical nature of early diagnosis for families with a history of HLS, the HYLS1 Gene Hydrolethalus Syndrome Genetic Test has become an essential tool in genetic counseling and prenatal care.
This genetic test specifically targets the HYLS1 gene to detect mutations that could lead to Hydrolethalus Syndrome. By analyzing the DNA, the test can provide vital information to expecting parents about the health of their fetus, enabling informed decisions during pregnancy. The test is particularly recommended for couples with a known family history of HLS or related symptoms, offering them a closer look at their baby's genetic health.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the HYLS1 Gene Test is performed with the utmost accuracy and confidentiality. The lab is equipped with state-of-the-art technology and staffed by professionals specialized in genetic diagnostics, ensuring high-quality results.
The cost of the HYLS1 Gene Hydrolethalus Syndrome Genetic Test is 4400 AED. While the price may seem significant, the value of the information it provides to at-risk families is immeasurable, potentially guiding critical healthcare decisions during pregnancy. It's important for interested individuals to consult with their healthcare provider or a genetic counselor to understand the implications of the test results fully and to determine if this test is appropriate for their specific situation.
ADK Gene Hypermethioninemia due to Adenosine Kinase Deficiency is a rare genetic disorder characterized by elevated levels of methionine in the blood, caused by mutations in the ADK gene. This condition can lead to a variety of health issues, including developmental delays, neurological problems, and liver disease. Early detection and management are crucial for improving the quality of life for affected individuals.
DNA Labs UAE offers a specialized genetic test to diagnose this condition, focusing on identifying mutations in the ADK gene. The test is a vital tool for families with a history of the disorder, as well as for individuals exhibiting symptoms consistent with hypermethioninemia. By analyzing the genetic makeup of the individual, the test can confirm the presence of the specific mutations responsible for adenosine kinase deficiency, facilitating accurate diagnosis and enabling tailored treatment plans.
The cost of the ADK Gene Hypermethioninemia due to Adenosine Kinase Deficiency Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the genetic alterations linked to the condition. Opting for this test at DNA Labs UAE ensures access to state-of-the-art genetic testing technologies, expert interpretation of results, and personalized care, all essential components in managing this rare genetic disorder effectively.
The "AHCY Gene Hypermethioninemia with Deficiency of S-Adenosylhomocysteine Hydrolase Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the AHCY gene, which are linked to a rare metabolic disorder. This condition is characterized by elevated levels of methionine in the blood due to a deficiency of the enzyme S-adenosylhomocysteine hydrolase. Individuals with this disorder may experience a range of symptoms, from mild to severe, including developmental delay, liver dysfunction, and neurological issues.
The test, which costs 4400 AED, is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. By examining the patient's DNA, the test can pinpoint specific genetic mutations in the AHCY gene, thus confirming a diagnosis of hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency. This information is crucial for developing an effective treatment plan and for genetic counseling to assess the risk of passing the condition on to offspring.
The PIGV Gene Hyperphosphatasia with Mental Retardation Syndrome Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the PIGV gene, which are linked to Hyperphosphatasia with Mental Retardation Syndrome Type 1 (HPMRS1). HPMRS1, also known as Mabry Syndrome, is a rare genetic disorder characterized by elevated levels of alkaline phosphatase, intellectual disability, distinct facial features, and, in some cases, seizures. The test plays a crucial role in the early diagnosis and management of the condition, providing essential information for genetic counseling and guiding treatment options. Priced at 4400 AED, the test is conducted using advanced genetic sequencing technologies to ensure accurate and reliable results. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures that individuals undergoing this test receive comprehensive support throughout the diagnostic process.
PIGO Gene Hyperphosphatasia with Mental Retardation Syndrome Type 2, also known as Mabry Syndrome, is a rare genetic disorder characterized by elevated levels of alkaline phosphatase, intellectual disability, and various physical anomalies. The condition is caused by mutations in the PIGO gene, which plays a crucial role in the glycosylphosphatidylinositol (GPI) anchor biosynthesis pathway, essential for the proper functioning of numerous proteins on the cell surface.
To diagnose this condition, a genetic test targeting the PIGO gene can be conducted. In the United Arab Emirates, DNA Labs UAE offers this specific test. The cost for the PIGO Gene Hyperphosphatasia with Mental Retardation Syndrome Type 2 Genetic Test is 4400 AED. This test is vital for confirming the diagnosis, allowing for appropriate management and genetic counseling for affected families. DNA Labs UAE utilizes advanced genomic technologies to provide accurate and reliable results, supporting patients and healthcare providers in the effective handling of this rare genetic syndrome.
The PGAP2 gene is associated with Hyperphosphatasia with Mental Retardation Syndrome Type 3 (HPMRS3), a rare genetic disorder characterized by significantly elevated levels of alkaline phosphatase, intellectual disability, and various physical anomalies. The PGAP2 gene plays a crucial role in the modification of proteins that are essential for normal brain development and function. Mutations in the PGAP2 gene disrupt these processes, leading to the symptoms observed in HPMRS3.
To diagnose this condition, a genetic test focusing on the PGAP2 gene can be conducted. This test is crucial for confirming the diagnosis, understanding the disease's progression, and facilitating the management of symptoms. It involves analyzing the DNA for mutations in the PGAP2 gene that are known to cause HPMRS3.
In the United Arab Emirates, DNA Labs UAE offers this specific genetic test for HPMRS3. The cost of the test is 4400 AED. Conducting the test at DNA Labs UAE ensures accuracy and reliability, as the lab is equipped with advanced genetic testing technologies and staffed by experts in the field. This test is a valuable resource for families seeking answers about HPMRS3, providing them with crucial information for making informed decisions about care and management.
